Abstract
Routine use of mupirocin to prevent staphylococcal infections is controversial. We assessed attitudes and practices of healthcare professionals attending the Fourth Decennial International Conference on Nosocomial and Healthcare-Associated Infections regarding mupirocin prophylaxis. Eighty percent of participants did not use mupirocin routinely. At the end of the session, 58% indicated they would consider increased use of mupirocin.
| Original language | English |
|---|---|
| Article number | 04423 |
| Pages (from-to) | 745-749 |
| Number of pages | 5 |
| Journal | Infection Control and Hospital Epidemiology |
| Volume | 21 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 1 Jan 2000 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Should we routinely use mupirocin to prevent staphylococcal infections?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver